The mechanism of arachidonic acid release in collagen-activated human platelets

Biosci Biotechnol Biochem. 1994 Jan;58(1):93-8. doi: 10.1271/bbb.58.93.

Abstract

The mechanism of arachidonic acid (AA) release in collagen-activated human platelets was studied. An arachidonic acid metabolite, thromboxane B2 (TXB2), was formed in parallel with the formation of phosphatidic acid (PA) without formation of lysophosphatidic acid (lysoPA) or lysophosphatidylinositol (lysoPI) in the absence of extracellular Ca2+, suggesting that AA was released from PI via a PI-specific phospholipase C (PI-PLC)/diacylglycerol (DG) lipase/monoacylglycerol (MG) lipase pathway under the cytosolic low Ca2+ concentrations. Moreover, solubilized DG lipase and MG lipase could hydrolyze the substrates at basal cytosolic free Ca2+ concentrations. Subsequently, the relationship of cytosolic free Ca2+ concentrations and formation of AA metabolites was analyzed using Ca2+ ionophore, A23187. Collagen was able to induce a release of small amounts of AA under basal cytosolic Ca2+ conditions. However, a release of large amounts of AA was induced by phospholipase A2 activated by both collagen-receptor occupancy and elevated Ca2+ levels. A TXA2 mimetic agonist, STA2 induced all the responses except for AA release. From these results, the mechanism of AA release and signal transduction in collagen-activated human platelets is discussed.

MeSH terms

  • Arachidonic Acid / metabolism*
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Calcium / metabolism
  • Collagen / pharmacology*
  • Cytosol / metabolism
  • Humans
  • In Vitro Techniques
  • Lipoprotein Lipase / blood
  • Lipoprotein Lipase / metabolism
  • Phospholipids / metabolism
  • Platelet Activation*
  • Thromboxane A2 / analogs & derivatives
  • Thromboxane A2 / pharmacology

Substances

  • Phospholipids
  • Arachidonic Acid
  • Thromboxane A2
  • STA 2
  • Collagen
  • Lipoprotein Lipase
  • Calcium